#AskHalftime Bristol-Myers & Qualcomm

#AskHalftime Bristol-Myers & QualcommПодробнее

Buy, hold or sell Qualcomm? #AskHalftimeПодробнее

Qualcomm beats Q4 estimates, announces $15B in share buybacksПодробнее

Qualcomm shares spike following quarterly beat on earnings and revenueПодробнее

Trade Tracker: Jim Lebenthal sells Nike and Bristol-Myers, buys UnitedHealthПодробнее

Trade Tracker: Stephanie Link buys ExxonMobil and Bristol MyersПодробнее

Market Snapshot | November 2024Подробнее

Merck, Bristol Myers and Pfizer...which one is most attractive? #AskHalftimeПодробнее

#AskHalftime: Bristol-MyersПодробнее

#AskHalftime: Coca-Cola dip, Qualcomm vs. Broadcom, and CATПодробнее

Chip Demand and A.I. to Drive QCOM & ARM HigherПодробнее

Markets’ post-election set-upПодробнее

Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cashПодробнее

Call of the Day: Oppenheimer raises bank targetsПодробнее

Trade Tracker: Rob Sechan sells Bristol Myers and buys more AbbvieПодробнее

Final Trades: PayPal, Merck, Bristol Myers & moreПодробнее

EARNINGS ALERT: QCOM, ARMПодробнее

Options Trades in QCOM, ARMПодробнее

Diversification "Value Play" for QCOM, ARM's Long-Term PromiseПодробнее

#AskHalftime on technology, mining, & communicationsПодробнее